Children'S Hosp-Kings Daughter

Norfolk, Virginia 23507-1910

0 studies enrolling now · 2 studies all time

What they study most

Hodgkin Disease, Leukemia, Pediatric

Studies at this site

• A Study of Nivolumab Plus Brentuximab Vedotin in Patients Between 5 and 30 Years Old, With Hodgkin's Lymphoma (cHL), Relapsed or Refractory From First Line Treatment — Completed
• Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia — Completed